American Oriental Bioengineering, Inc.
AOBI · OTC
9/30/2013 | 6/30/2013 | 3/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Market Cap | $4 | $4 | $4 | $14 |
| - Cash | $3 | $7 | $6 | $7 |
| + Debt | $93 | $65 | $63 | $68 |
| Enterprise Value | $94 | $62 | $60 | $75 |
| Revenue | $18 | $20 | $21 | $62 |
| % Growth | -11.3% | -3.7% | -66.3% | – |
| Gross Profit | $3 | $5 | $5 | $27 |
| % Margin | 17.3% | 24.7% | 21.4% | 43.3% |
| EBITDA | -$16 | -$7 | -$17 | -$31 |
| % Margin | -89.3% | -35.8% | -80.8% | -50% |
| Net Income | -$21 | -$13 | -$21 | -$36 |
| % Margin | -118.1% | -63.5% | -100.5% | -57.5% |
| EPS Diluted | -290.36 | -176.28 | -288.69 | -485.66 |
| % Growth | -64.7% | 38.9% | 40.6% | – |
| Operating Cash Flow | -$17 | -$3 | -$2 | -$9 |
| Capital Expenditures | -$14 | -$1 | -$0 | -$13 |
| Free Cash Flow | -$31 | -$4 | -$2 | -$23 |